Natixis Investment Managers International’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,200
Closed -$501K 717
2018
Q2
$501K Hold
3,200
0.03% 411
2018
Q1
$515K Buy
+3,200
New +$515K 0.04% 260